Pathstone Holdings, LLC Exelixis, Inc. Transaction History
Pathstone Holdings, LLC
- $22.3 Billion
- Q3 2024
A detailed history of Pathstone Holdings, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 12,500 shares of EXEL stock, worth $439,875. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,500
Previous 12,016
4.03%
Holding current value
$439,875
Previous $269,000
20.45%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EXEL
# of Institutions
481Shares Held
244MCall Options Held
1.92MPut Options Held
1.4M-
Black Rock Inc. New York, NY33.5MShares$1.18 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.3MShares$1.03 Billion0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA25.4MShares$894 Million3.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.4MShares$541 Million0.63% of portfolio
-
State Street Corp Boston, MA11.4MShares$403 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.3B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...